Panama Pharmaceutical Licensing

Article 379 of Executive Decree No. 27 provides that pharmaceutical premises, whether public or private, engaging in the manufacture, packaging, procurement, import, export, re-export, storage, distribution, dispensing, wholesale or retail sale of regulated products must apply to DNFD for and hold an operating licence. Raw materials used in the pharmaceutical industry, cosmetics and similar products are also covered by that article. This is authorisation for the business/premises, not for a product or an individual professional.

This review is based on nationwide MINSA/DNFD documents; no materials were found that would support a general statement that provinces or municipalities issue separate pharmaceutical operating licences. Projects should still separately verify general commercial, construction, fire-safety or municipal requirements applicable at the location. These should not be mischaracterised as DNFD pharmaceutical licences.

The DNFD opening application requires legal entities to provide proof of public registration, but the materials opened in this review do not specify uniform foreign-investment restrictions, mandatory corporate forms, minimum capital or minimum floor-area rules. Shareholder nationality, company type, capital or floor-area thresholds should therefore not be assumed.

— First distinguish the business categories: Farmacia, Droguería, Agencia Distribuidora, manufacturing laboratory, packaging laboratory and other form categories.

— Medicines may be sold through an online platform only by premises that are already authorised/registered, and the activity must be applied for to be included. The regulations specifically refer to medicines labelled “venta popular” (non-prescription sale) in relation to this platform rule.

— The specific re-export exception for the Colón Free Zone is subject to strict conditions and must not be extended into a general exemption for operating a pharmaceutical business in Panama.

MINSA is the health authority, and DNFD is the specialised department responsible for operating-premises licences, forms, inspections and pharmaceutical regulatory matters. DNFD's 2024 form expressly requires applicants to select, according to the category of premises, whether the application is for initial opening, renewal or amendment of a licence.

The Ministry of Health’s 2024 explanatory materials state that Law No. 419 (1/2/2024) replaced Law No. 1 (2001), while article 1 of Executive Decree No. 27 states that it implements Law No. 419. This guide therefore uses Decree No. 27 and the 2024 DNFD forms as its main current basis; the 2020 electronic guide is retained only as a historical procedural reference, and its one-year validity period or estimated processing times are not used to override the new rules.

— MINSA: health administrative authority.

— DNFD: implementing department for operating licences, inspections, registrations, import authorisations and related pharmaceutical regulation.

— Individual professional eligibility: distinct from a premises licence and must be confirmed separately under the applicable procedures for pharmacists and related professions.

For an initial opening, a pharmacy should select the Farmacia category and obtain a DNFD operating licence. The 2024 form lists its activities as bulk procurement, storage and retail sale of medicines, as well as dispensing against prescriptions where applicable. Retail delivery through a digital platform or call centre is also listed separately and should be truthfully selected among the activities applied for. Hospital pharmacies have a separate business description and should not be confused with community pharmacies.

The pharmacy's name signage, physical address, opening hours and licence must be consistent with one another; the licence must be valid and visible to the public. The pharmacy must allow DNFD inspections and may not house a human or veterinary medical clinic, or any department thereof, within the pharmacy.

A pharmacy may procure medicines only from authorised distribution establishments holding a valid DNFD operating licence. On receipt, it should verify the health registration, manufacturer, country of origin, batch number, expiry date and other particulars, and provide a segregated area for expired/damaged products. Medicines without health registration or DNFD authorisation may not be sold.

— After obtaining its initial licence, the pharmacy should apply to DNFD for the stamping of an ordinary prescription transcription book.

— If handling controlled drugs, a dedicated area meeting controlled-substance rules must be provided and records kept under the relevant specific rules; an ordinary pharmacy operating licence is not itself a controlled-drug permit.

— Injectable medicines may not be administered in the pharmacy; online activities must not exceed the authorised scope.

Swipe horizontally to view all items

The DNFD form describes a Droguería as covering the import and wholesale of medicines, while an Agencia Distribuidora covers the import, distribution, storage and wholesale of authorised products. The actual application should map each activity—by product type, import, warehousing, distribution, wholesale, re-export and so on. Similar names do not mean that one licence category automatically covers all activities of another.

Relevant premises with storage areas and transport vehicles are subject to good storage, distribution and transport requirements. DNFD uses the relevant guidelines to verify opening, routine inspections and the authorisation of distribution establishments. Operators must maintain quality-system documents, job responsibilities, an organisational chart, standard operating procedures and traceability records.

Warehousing premises should have adequate capacity, controlled access and clearly designated areas for receiving, storage, controlled substances, flammable materials, cold chain, quarantine, recalls/returns, expired products, picking and dispatch. The surrounding environment must not pose a contamination risk to products, and cleaning, pest control, maintenance and emergency measures must be in place.

— The pharmacist technical manager is the technical supervisor and oversees activities relating to receipt, warehousing, import/export, distribution, trade and disposal of pharmaceutical waste.

— A person responsible for the quality system must be separately appointed; all personnel must have records of initial and ongoing training relevant to their responsibilities.

— For import, warehousing and wholesale activities, the technical manager's hours may be less than full-time but must be no fewer than four hours per day, and must be declared.

A manufacturing laboratory should carry out import of raw materials/bulk products, manufacturing, packaging, sales and related export activities only within the scope stated in its operating licence. The DNFD form also includes a packaging laboratory category for primary, secondary or tertiary packaging of finished products, changing package inserts, and marking batch numbers, Panama health registration numbers and expiry dates. The boundary between manufacturing and packaging must be confirmed based on the actual process.

DNFD conducts an on-site inspection before issuing a new operating licence for pharmaceutical premises, verifying that the premises have the infrastructure, equipment, hygiene and environmental conditions required for manufacturing, storage and product handling for the relevant category. Manufacturing facilities should use suitable, robust construction that facilitates cleaning and maintenance, and a layout that reduces the risk of contamination, mix-ups and errors.

For laboratory renewals, DNFD materials require submission of valid GMP evidence. Product manufacturing does not remove the need for product health registration, import requirements, batch documentation or additional requirements for special products. For example, imported biological/biotechnological products have separate requirements for batch analysis or release documentation.

— The pharmacist technical manager for pharmaceutical manufacturing must be present for eight hours per day.

— Pharmaceutical manufacturers should assign production, quality control and quality assurance responsibilities; the head of quality assurance may also serve as technical manager, but the functions must remain independent.

— Trial production, commercial production or packaging should not be treated as authorised activities before the DNFD pre-opening on-site inspection is completed and the licence is obtained.

For an initial application, submit identification documents for the owner or legal representative and the technical director who holds the requisite pharmacist qualification. If the technical director also works at another establishment, attach proof issued by that establishment specifying the technical director’s working hours. The form requires the responsible person’s name, qualification number and working hours.

The pharmacist technical director is a key person responsible for the technical management of the establishment. For pharmaceutical manufacturing, the required time is eight hours per day; for import, warehousing and wholesale distribution, hours may be declared, but the minimum is four hours per day. If the position is vacant because of dismissal, the operating licence will be suspended; if the vacancy arises for other reasons, there is a period of up to 30 working days to fill it.

Pharmacy staff should hold identification cards showing their job titles and qualifications. The establishment should keep an individual file for each employee, including training and learning materials. Pharmacy personnel must also undergo an annual health examination; qualified personnel should be trained to report suspected adverse reactions, treatment failures and quality defects.

— Before applying, the company should confirm that the proposed technical director’s personal qualification is valid and separately address their professional registration/licensing matters.

— A change of pharmacist technical director must be submitted as a licence amendment, with the new director’s information, proof of working hours at other establishments, and departure/dismissal and handover or appointment documents.

— Training, job responsibilities and operational records should be made available to the health authority.

Before a new pharmaceutical establishment is licensed, DNFD must conduct a pre-opening inspection to verify that it has the infrastructure, equipment, sanitation and environmental conditions needed for manufacturing, storage and product handling according to the type of establishment. The inspection uses the applicable category-specific pre-opening record or guidelines. The technical director should be present; if they cannot attend, a written explanation is required. The application must also include a floor plan showing the internal areas and the premises’ area in square metres.

A pharmacy should be constructed of suitable durable materials and have ceilings, walls and floors in good condition. It should have a toilet and an area for staff meals separate from the work area, and be equipped with lighting, ventilation, temperature and humidity monitoring, records taken at least twice daily, fire and emergency equipment, and systems for maintenance, pest control and cleaning records. The regulations specify space suitable for the work, not a uniform minimum area that this guide can confirm.

General storage areas must not be used to store food or toxic products together with medicines; products must be kept in segregated, identified and designated areas. Where inventories are large, pharmacies must have clearly labelled storage areas and inventory and expiry-date systems. Refrigerated products require a dedicated refrigerator, and controlled drugs require an appropriate secure area.

— Manufacturing and warehousing/distribution operations should designate areas for receiving, quarantine, cold chain, controlled products, flammables, returns, expired products, order preparation and dispatch, as appropriate to their activities.

— Establishments should implement measures for contamination prevention, pest control, preventive maintenance, cleaning records, access control, and fire and environmental compliance.

— Do not interpret the square-metre figure required on the application plan as meaning that an official, nationwide uniform minimum area has been established.

DNFD provides the application form for an operating licence for pharmaceutical establishments free of charge. For an initial opening, complete the form for the relevant establishment category and attach, where applicable, a notarised authorisation, the legal entity’s public registry certificate, identification documents for the legal representative or owner and the pharmacist technical director, proof of the technical director’s working hours at other establishments, a floor plan showing internal areas and square metres, and the applicable service fee.

After completing the document review, DNFD conducts a pre-opening inspection of the new establishment. If the review raises observations, the applicant has up to 20 working days from the date of notification to address them. After that period, the application is returned and the process must be initiated again. The licence must be obtained before opening; submitting an application, having a layout pre-reviewed or scheduling an inspection is not a substitute.

The application form distinguishes initial opening, renewal and amendment. First determine one establishment and one combination of category/activities. If retail, import, wholesale, manufacturing, packaging or logistics services are planned concurrently, ask DNFD in advance to confirm whether multiple categories or activities must be included.

— Define the physical premises, actual activities, product scope, technical director and quality responsibilities.

— Prepare the legal entity/owner, technical director, layout and payment documents using the current DNFD form.

— Undergo DNFD’s pre-opening inspection and respond to any observations within the statutory correction period specified in the notification.

— After obtaining and displaying the licence, commence operations within the authorised activities; pharmacies must separately have the ordinary prescription transcription register stamped.

Article 398 of Executive Decree No. 27 provides that an operating licence for a pharmaceutical establishment is valid for two years from the date of issue; a renewal application must be submitted one month before expiry. If the information previously submitted has not changed during the licence period, a notarised declaration of no changes may be submitted. DNFD may then issue the renewal through an expedited process, but may still verify the truth of the declaration at any time.

DNFD’s 2024 form lists the following fees: pharmacy operating licence, B/.50.00; Agencia Distribuidora, laboratory and Droguería, B/.200.00 each; initial premises inspection, B/.50.00; licence amendment, B/.20.00. The form also lists a fee for the pharmacy controlled-substances quarterly report form. These are the listed service amounts for pharmaceutical establishments and must not be extrapolated to product health registrations, imports, controlled products or other administrative services.

The current decree specifies the maximum correction period and the advance period for renewal, but this review did not find a general statutory approval timeframe applicable to all categories. Approximate processing times and a one-year validity period appearing in an older 2020 electronic guide should not be used to promise current processing times or licence validity.

— Licence: valid for two years from the date of issue.

— Renewal: submit at least one month before expiry.

— Correction of observations: up to 20 working days from the date of notification; after that, the application is returned and the process must be restarted.

— Completion time: confirm with DNFD based on its actual receipt and handling of the application, inspections, corrections and product complexity.

Swipe horizontally to view all items

After licensing, maintain the address, business hours, technical director and authorised activities recorded on the licence. Pharmacies must display a valid licence. DNFD may inspect all public and private premises that handle or use medicines during the declared business hours, and operators must immediately allow the health authority to enter for supervision.

Premises engaged in warehousing, distribution and transport should maintain quality-system documents, including an organisational chart, job descriptions, SOPs, and records for receipt, storage, dispatch, cold chain, transport, maintenance, recalls, returns, disposal and pest control. Procedures and records should be traceable and readily retrievable, and reviewed by appropriate personnel, including the technical director.

Establishments must have arrangements for handling returns, complaints, recalls and suspected illegal or counterfeit products. If a product is suspected of being counterfeit or illegal, immediately notify DNFD, segregate the product and submit relevant information and a quantity report. Pharmaceutical manufacturers and distribution agents must also establish a pharmacovigilance system and designate a health professional with the required qualifications and pharmacovigilance knowledge.

— Conduct at least one warehouse self-inspection each year and be prepared for DNFD investigations or audits.

— Laboratory renewal applications must include valid GMP evidence; other categories should prepare renewal documents and fees in accordance with the DNFD form.

— If a pharmacy suspends operations or closes permanently, notify DNFD in writing and remain responsible for storage, inventory and final disposal of stock.

During the licence validity period, changes to the technical director, legal representative, owner, legal entity, board of directors, addition of activities and change of premises are matters requiring a DNFD licence amendment. An amendment application generally requires the form, a notarised authorisation where applicable, the service fee and the original licence, with additional documents depending on the type of change.

A change of owner or legal representative requires identification documents; a change of owner also requires a valid public registry certificate evidencing the change and a sale and purchase agreement. A change to the legal entity or board of directors requires a valid public registry certificate. A change of technical director requires information about the new director, proof of working hours at other establishments where applicable, resignation/dismissal documents, and handover or appointment documents for the outgoing and incoming directors.

Expansion of activities, change of address, or even reconfiguration within the same premises must be clearly specified in the application and is subject to inspection; a location plan must be submitted. Structural changes that do not alter the information recorded on the licence must also be notified to DNFD in writing and may be inspected.

— Before signing a transaction, identify whether it will trigger a change to the owner, legal representative, legal entity, board of directors, technical director or premises.

— Do not treat a new address, expanded activities or an expanded distribution/warehousing area as authorised without a DNFD amendment and any required inspection.

— If deciding to discontinue activities, notify DNFD in writing under Articles 399 and 401 and deal with the inventory.

Swipe horizontally to view all items

An operating licence for a pharmaceutical establishment and a product health registration (registro sanitario) are related but distinct. Executive Decree No. 27 provides that an applicant importing products covered by Law No. 419 must obtain DNFD authorisation. For imports of medicines and other human health products, the importer must also hold an operating licence that includes import activities and have a valid product health registration, registration, exemption/authorisation from registration, or import certificate under a valid health registration for the product. The importer must also prepare the customs pre-declaration, compliant invoice and, where applicable, packing list and manifest.

Accordingly, obtaining an operating licence for a retail, wholesale or manufacturing establishment does not automatically authorise the sale of unregistered products or imports. Pharmacies must not sell medicines without a health registration or DNFD authorisation. Special products may require additional documents, such as batch analysis or release documents for the import and commercialisation of biological/biotechnological products.

Finished medicinal products containing controlled precursors and controlled drugs are also subject to controlled-substances requirements. A pharmacy handling controlled drugs must provide a dedicated area and keep records under the applicable rules. Import and sale of radiopharmaceuticals also require a permit for the import, transport and handling of radioactive products issued by the Directorate General of Public Health.

— First confirm the health registration, registration, exemption or specific authorisation status of each SKU.

— Before importing, confirm that import is included among the activities on the operating licence, and obtain DNFD import authorisation and customs-clearance documents.

— Establish a separate permit/document checklist for controlled substances, precursors, radioactive, biological, cold-chain or other special products.